-+ 0.00%
-+ 0.00%
-+ 0.00%

IMUNON - IDMC RECOMMENDS PHASE 2 MRD STUDY CONTINUE WITHOUT MODIFICATION AFTER SAFETY REVIEW

路透·09/22/2026 12:10:20

请登录查看新闻详情